2022
DOI: 10.3389/fphys.2022.953880
|View full text |Cite
|
Sign up to set email alerts
|

Post-transcriptional control by RNA-binding proteins in diabetes and its related complications

Abstract: Diabetes mellitus (DM) is a fast-growing chronic metabolic disorder that leads to significant health, social, and economic problems worldwide. Chronic hyperglycemia caused by DM leads to multiple devastating complications, including macrovascular complications and microvascular complications, such as diabetic cardiovascular disease, diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy. Numerous studies provide growing evidence that aberrant expression of and mutations in RNA-binding proteins (RB… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 139 publications
0
0
0
Order By: Relevance
“…Other proteins in the same family, like RBPs, are involved in various processes in pancreatic β-cells, including insulin synthesis and secretion. Their expression in glucose-induced β-cells is mediated by the insulin receptor signaling pathway, which can decrease their expression [73].…”
Section: Discussionmentioning
confidence: 99%
“…Other proteins in the same family, like RBPs, are involved in various processes in pancreatic β-cells, including insulin synthesis and secretion. Their expression in glucose-induced β-cells is mediated by the insulin receptor signaling pathway, which can decrease their expression [73].…”
Section: Discussionmentioning
confidence: 99%
“…Splicing factors are essential in regulating RNA splicing by recognizing specific cis-regulatory sequences 20 . The expression levels of some spliceosome and RNA binding proteins (RBPs), which were significantly altered in insulin-resistant or T2D donors, were associated with the progress of the disease 21 , 22 . Splicing factors, NOVA1 , NOVA2 , ELAVL4 , PRFP8 / PRP8 , etc., which encode splicing factors or major spliceosomes, regulate insulin secretion or β-cell survivals 10 , 23 .…”
Section: Introductionmentioning
confidence: 99%